WAVE Life Sciences Ltd (WVE):企業の財務・戦略的SWOT分析

◆英語タイトル:WAVE Life Sciences Ltd (WVE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH2305299FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Wave Life Sciences Ltd (Wave Life Sciences) formerly WAVE Life Sciences Pte Ltd, discovers, develops and commercializes medicines for genetic diseases. The company’s pipeline comprises an mRNA transcript candidates: WVE-120101 and WVE-120102 for Huntington’s disease; ATXN3 gene candidate for Spinocerebellar ataxia 3; C9orf72 gene candidate for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD); USH2A and RhoP23H candidate for retinal diseases; and multiple candidates for other central nervous system (CNS) disorders, and hepatic diseases. The company employs its proprietary chemistry platform to design, optimize and manufacture stereopure oligonucleotides with improved safety, tolerability and efficacy compared to that of stereorandom oligonucleotides. Wave Life Sciences is jointly advancing its CNS pipeline candidates in collaboration with Takeda. It has operations in Singapore, the US, Japan, the UK and Ireland. Wave Life Sciences is headquartered in Singapore.

Wave Life Sciences Ltd Key Recent Developments

Mar 04,2021: Wave Life Sciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 23,2021: Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
Feb 16,2021: Wave Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Jan 07,2021: Wave Life Sciences : Change in Directors or Principal Officers
Dec 02,2020: Wave Life Sciences announces appointment of Jonathan Rosin as Chief Human Resources Officer

This comprehensive SWOT profile of Wave Life Sciences Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Wave Life Sciences Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

WAVE Life Sciences Ltd – Key Information
WAVE Life Sciences Ltd – Overview
WAVE Life Sciences Ltd – Key Employees
WAVE Life Sciences Ltd – Key Employee Biographies
WAVE Life Sciences Ltd – Key Operational Heads
WAVE Life Sciences Ltd – Major Products and Services
WAVE Life Sciences Ltd – History
WAVE Life Sciences Ltd – Company Statement
WAVE Life Sciences Ltd – Locations And Subsidiaries
WAVE Life Sciences Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

WAVE Life Sciences Ltd – Business Description
WAVE Life Sciences Ltd – Corporate Strategy
WAVE Life Sciences Ltd – SWOT Analysis
SWOT Analysis – Overview
WAVE Life Sciences Ltd – Strengths
WAVE Life Sciences Ltd – Weaknesses
WAVE Life Sciences Ltd – Opportunities
WAVE Life Sciences Ltd – Threats
WAVE Life Sciences Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

WAVE Life Sciences Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

WAVE Life Sciences Ltd, Key Information
WAVE Life Sciences Ltd, Key Ratios
WAVE Life Sciences Ltd, Share Data
WAVE Life Sciences Ltd, Major Products and Services
WAVE Life Sciences Ltd, History
WAVE Life Sciences Ltd, Key Employees
WAVE Life Sciences Ltd, Key Employee Biographies
WAVE Life Sciences Ltd, Key Operational Heads
WAVE Life Sciences Ltd, Other Locations
WAVE Life Sciences Ltd, Subsidiaries
WAVE Life Sciences Ltd, Key Competitors
WAVE Life Sciences Ltd, SWOT Analysis
WAVE Life Sciences Ltd, Ratios based on current share price
WAVE Life Sciences Ltd, Annual Ratios
WAVE Life Sciences Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[WAVE Life Sciences Ltd (WVE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amazon.com Inc (AMZN):企業の財務・戦略的SWOT分析
    Amazon.com Inc (AMZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Duke Energy Carolinas LLC-エネルギー分野:企業M&A・提携分析
    Summary Duke Energy Carolinas, LLC (Duke Energy Carolinas), a subsidiary of Duke Energy Corporation, is a regulated electric utility, which generates, transmits, distributes and sells energy. The company produces power from nuclear, coal, oil and gas, hydro, and solar sources. It is subject to the r …
  • Transocean Ltd.:企業の戦略・SWOT・財務情報
    Transocean Ltd. - Strategy, SWOT and Corporate Finance Report Summary Transocean Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Carmat SAS (ALCAR)-医療機器分野:企業M&A・提携分析
    Summary Carmat SAS (Carmat) is a medical equipment company that offers artificial organs. The company offers development of innovative artificial organs, artificial heart and other vital organs. Its artificial heart products consists of an implantable heart, and components which help connect to an e …
  • The Coffee Club Franchising Company Pty Ltd:企業の戦略・SWOT・財務分析
    The Coffee Club Franchising Company Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary The Coffee Club Franchising Company Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Echosens SA:医療機器:M&Aディール及び事業提携情報
    Summary Echosens SA (Echosens), a subsidiary of Inner Mongolia Free Han & Mongolia Pharmaceutical Co Ltd, is a medical device company that offers diagnostic products. The company designs and develops diagnosis solutions for patients with chronic liver diseases. It offers fibrometer, fibroscan, fibro …
  • Brigham and Women’s Hospital-医療機器分野:企業M&A・提携分析
    Summary Brigham and Women's Hospital (BWH) is a healthcare service provider that offers patient care services. The hospital offers care coordination, ethics consultation, interpreter services, Kessler library, nutrition, patient and family relations, pharmacy, security and safety, and spiritual care …
  • Bacardi Ltd:企業の戦略的SWOT分析
    Bacardi Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Metro Pacific Investments Corporation:企業のM&A・事業提携・投資動向
    Metro Pacific Investments Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Metro Pacific Investments Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • C.H. Bailey PLC:企業の戦略・SWOT・財務分析
    C.H. Bailey PLC - Strategy, SWOT and Corporate Finance Report Summary C.H. Bailey PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Hitachi Chemical Co Ltd (4217):企業の財務・戦略的SWOT分析
    Hitachi Chemical Co Ltd (4217) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Alamos Gold Inc.:企業の戦略・SWOT・財務情報
    Alamos Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Alamos Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hyundai Steel Co:企業の戦略・SWOT・財務情報
    Hyundai Steel Co - Strategy, SWOT and Corporate Finance Report Summary Hyundai Steel Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Leukocare AG:医療機器:M&Aディール及び事業提携情報
    Summary Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying proce …
  • Freudenberg & Co KG:企業の戦略的SWOT分析
    Freudenberg & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Bankinter, S.A.:企業の戦略・SWOT・財務情報
    Bankinter, S.A. - Strategy, SWOT and Corporate Finance Report Summary Bankinter, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Billabong International Limited (BBG):企業の財務・戦略的SWOT分析
    Billabong International Limited (BBG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • WPG Holdings Limited:企業の戦略・SWOT・財務情報
    WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • curasan AG (CUR):製薬・医療:M&Aディール及び事業提携情報
    Summary curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, ora …
  • U.S. Concrete Inc (USCR):企業の財務・戦略的SWOT分析
    Summary U.S. Concrete Inc (US Concrete) is a construction company that manufactures and markets ready-mixed concrete and aggregates. The company’s aggregate products include crushed stone, sand and gravel used in commercial, industrial and public works. It also provides specialty products such as ra …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆